While the internationalization is facing multiform barriers and various problems in our running , the management and actuality of herbal medicine in japan and germany and the existing problems of chinese materia medica management have been reviewed in this paper , so as to put forward some advices for the management reform adapting to the internationalization of chinese materia medica industry 从日本和德国植物药管理与发展现状中吸取经验，针对我国现行的中药管理存在的问题，提出了加强管理以促进中药产业国际化的几点建议。
We studied situation of the international botanical drug ' s registration and quality control , summarized three main modes of the quality control and analyze the difference and homology of the two control system represented by the europe - usa & japan separately . the development of botanical drug ' s quality control is also discussed in our study 本课题研究了国际植物药注册和质量控制现状，总结出植物药质量控制的三种主要模式，并分析了以欧美为首的化学成分控制模式和日本为首的标准汤剂控制模式的相同点和不同点，探讨了植物药质量控制的发展趋势。
The germplasm of medicinal plant is the key in the course of plant medicine producing . lt has direct relation to cultivation of medicinal plant and the quality of crude drug . at present , there is a large - scape area in the cultivation of dioscorea plant with high diogenin , but for neglecting the unstability of germplasm and breeding of valuable cultivars , the quality is not enough to use as crude drug , which lead to supply falling short of demand . therefore , keeping stability of good germplasm , as well as breeding new dioscorea cultivars with high diogenin and yield is urgent and valuable to study 在我国，盾叶薯蓣和穿龙薯蓣等因为较高的薯蓣皂甙元含量，都有很大的栽培面积，但作为原料药其产量和质量并未达到植物药生产所需，导致市场供需矛盾十分突出，就是因为只简单地将野生资源挖回来种植，忽略了种质的不稳定和有栽培价值的品种的培育，因而保持优良种质的稳定性和培育高含量、高产量的薯蓣新品种是一个紧迫而又有价值的研究课题。
Therefore , the seminar will deepen the understanding of chinese local governments , companies and research institutes upon tcms current situation in uk , mechanism on tcms access into uks market and relevant rules and regulations so that the internationalisation of tcm and its progressive development in the western countries will be stimulated 通过此次研讨会活动，将加深本地政府，企业和科研机构对英国植物药研究的现状和相关准入标准及政策法规的了解，促进中医药的国际化，推动其在西方市场的更大发展。
